OrigoBio
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- $14M
Investors
- 6
About OrigoBio
, dba OrigoBio, has established a research and development platform called NCVx, built on intelligent nanovesicle technology. The company’s core scientific achievements have been published in leading international journals such as Nature, Matter, and JACS, and its innovations have progressed toward clinical application. OrigoBio develops therapeutic solutions leveraging nanovesicle technology for tissue repair and regenerative medicine. The company's NCVx platform integrates intelligent nanovesicle engineering to enable novel treatment approaches, targeting applications across healthcare and clinical practice. The company is expected to generate revenue from the development, licensing, and commercialization of nanovesicle-based therapies, as well as from research collaborations in regenerative medicine.
Who invested in OrigoBio
6 investors across 2 rounds
See all investors in OrigoBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OrigoBio
Who invested in OrigoBio?
OrigoBio has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OrigoBio raised?
OrigoBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did OrigoBio last raise money?
OrigoBio's most recent round on record is a Series A, in Jul 2026.
What does OrigoBio do?
, dba OrigoBio, has established a research and development platform called NCVx, built on intelligent nanovesicle technology.
Where is OrigoBio headquartered?
OrigoBio is headquartered in Hangzhou, China.
Which VCs invest in companies like OrigoBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at OrigoBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like OrigoBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.